Beautiful Virgin Islands

Sunday, Jul 20, 2025

Developing New Version Of Sputnik Vaccine Adapted To 'Omicron': Russia

Developing New Version Of Sputnik Vaccine Adapted To 'Omicron': Russia

The Russian Direct Investment Fund (RDIF), which supported the vaccine's development by the state-run Gamaleya Center, said that the centre "has already begun developing the new version of Sputnik vaccine adapted to Omicron."
The backers of the Russian Covid-19 vaccine Sputnik V said Monday that the jab is effective against the new 'Omicron' coronavirus variant but they were also developing an adapted booster.

The Russian Direct Investment Fund (RDIF), which supported the vaccine's development by the state-run Gamaleya Center, said that the centre "has already begun developing the new version of Sputnik vaccine adapted to 'Omicron'."

"In an unlikely case such modification is needed, the new Sputnik 'Omicron' version can be ready for mass-scale production in 45 days," RDIF said in a statement.

"Several hundred million Sputnik 'Omicron' boosters can be provided to international markets already by February 20, 2022 with over 3 billion doses available in 2022."

The promise comes after the US pharmaceutical company Moderna said Friday that it will develop a booster shot against the highly mutated strain of the coronavirus, which is more transmissible than the dominant Delta variant.

Germany's BioNTech and US drugmaker Pfizer said the same day that they expect data "in two weeks at the latest" to show if their jab can be adjusted.

Last week RDIF said Sputnik V provides longer immunity against the coronavirus than Western jabs using messenger RNA (mRNA) technology.

It added that the Sputnik vaccine is 80 percent effective against the coronavirus between six and eight months after the second dose.

No independent study has confirmed the claim.

Russia registered Sputnik V last August ahead of large-scale clinical trials, prompting concern among experts over the fast-tracked process.

But it was since declared safe and over 90 percent effective in a report published by leading medical journal The Lancet.

The RDIF says its two-dose vaccine has been approved in 71 countries and that it has applied for registration in the European Union.

Earlier this summer several Latin American countries that have relied on the Russian vaccine to protect their populations complained to Moscow about delivery delays.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
×